Clinical Trial Update: A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, randomized, placebo-controlled trial evaluating ambroxol treatment for Amyotrophic Lateral Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Ambroxol (Ambroxol)

Snippet

Sponsor: The Florey Institute of Neuroscience and Mental Health | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: UNKNOWN